AIM
SRNE

Alambic Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Alambic Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-417,034
Closed -$2.15M – 478
2018
Q1 		$2.15M Buy
417,034
+377,182
+946% +$1.94M 0.3% 122
2017
Q4 		$151K Buy
+39,852
New +$151K 0.02% 424